Williams Jeremy D. sold $487K of CNO

Williams Jeremy D. (Chief Actuary) sold 8,782 shares of CNO Financial Group, Inc. (CNO) at an average of $55.49 ($55.27–$55.72, $0.49M total) across 3 trades over 2026-09-15 to 2026-09-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Williams Jeremy D.
Published Sep 16, 2026, 10:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 10:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNO
Neutral
high confidence
Mentioned
$CNO
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

The sale is a routine disclosure with limited market impact.

02

Market read

Minor insider sale; unlikely to move the stock price materially.

03

What to watch

Potential tax planning motives or portfolio rebalancing unrelated to company performance.

Relevance 3/10Novelty 4/10Timing: on 2026-09-16

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$CNONeutralHigh confidence
Context

Chief Actuary Jeremy D. Williams sold 8,782 shares for $487,321 via a 10b5‑1 plan on 2026‑09‑15/16.

Expected impact

Minimal short‑term impact; likely absorbed without significant price movement.

Evidence & confidence

The transaction size is modest relative to market cap and was pre‑arranged, suggesting no new negative information.

Market effects

None; the sale does not affect the broader financial services sector.

No regional impact; limited to CNO shareholders.

Insignificant on a global scale.

Counterpoint

If the insider had hidden concerns, the sale could signal future weakness, but the 10b5‑1 plan reduces this risk.

Key entities

  • Williams Jeremy D.

    Chief Actuary of CNO Financial Group, Inc.

  • CNO Financial Group, Inc.

    U.S. insurance and financial services firm (ticker CNO).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNOMed

CNO Financial Group Inc (CNO) (Q3 2026) Earnings Call Highlights: Raised Guidance

CNO Financial Group reported Q3 2026 earnings, raising guidance. Life NAP decreased 9% due to a discontinued program. Medicare Supplement results were impacted by higher morbidity. Free cash flow guidance tightened to $220-$240M. Net investment income increased 72%, but $12M is not expected to continue. The company discussed reinsurance deals, expense management, and economic pressures. CEO Gary Bhojwani noted structural demand drivers for their services.

$CNOHighAI 8/10

CNO Financial (CNO) Q3 2026 Earnings Call Transcript

CNO Financial reported Q3 2026 earnings, highlighting 4% growth in agent count and strong sales across divisions. Medicare Supplement NAP surged 41%, and Life NAP rose 20% excluding a discontinued program. Annuity premiums increased 9%, and brokerage assets grew 15%. Operating EPS reached $1.90, up 47% YoY. The company ceded $270M in life reserves to CNO Bermuda Re for capital optimization.

$CNOMedAI 8/10

What CNO Financial Group (CNO) Said on Its Q3 Earnings Call

CNO Financial Group reported Q3 operating EPS of $1.42, up 48% YoY. Sales grew in life, hospital indemnity, and accident products. Investment income rose 13%, and the company returned $77M to shareholders. CNO updated its 2026 outlook, lowering the expense ratio and raising EPS estimates. The company also completed a reinsurance transaction with its Bermuda affiliate.